Bruker Expands Clinical Microbiology and Infection Diagnostics Portfolio
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
The Oncoguard Esophagus test showed high sensitivity and specificity for the detection of esophageal adenocarcinoma and its precursors.
Researchers developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests.
A new study has revealed disparities in the diagnosis and treatment of Lyme disease between Black and White patients with the condition.
Researchers demonstrated that metal-enhanced fluorescence probes could rapidly detect influenza virus proteins without complex lab equipment.
Biomerica received FDA 510(k) clearance for a new test designed to detect the presence of the H. pylori bacteria.
NOWDiagnostics submitted a De Novo Classification Request to the U.S. FDA for the company's First to Know at-home syphilis test.